[PDF][PDF] Homeostatic control of Hpo/MST kinase activity through autophosphorylation-dependent recruitment of the STRIPAK PP2A phosphatase complex

Y Zheng, B Liu, L Wang, H Lei, KDP Prieto, D Pan - Cell reports, 2017 - cell.com
Y Zheng, B Liu, L Wang, H Lei, KDP Prieto, D Pan
Cell reports, 2017cell.com
The Hippo pathway controls organ size and tissue homeostasis through a kinase cascade
leading from the Ste20-like kinase Hpo (MST1/2 in mammals) to the transcriptional
coactivator Yki (YAP/TAZ in mammals). Whereas previous studies have uncovered positive
and negative regulators of Hpo/MST, how they are integrated to maintain signaling
homeostasis remains poorly understood. Here, we identify a self-restricting mechanism
whereby autophosphorylation of an unstructured linker in Hpo/MST creates docking sites for …
Summary
The Hippo pathway controls organ size and tissue homeostasis through a kinase cascade leading from the Ste20-like kinase Hpo (MST1/2 in mammals) to the transcriptional coactivator Yki (YAP/TAZ in mammals). Whereas previous studies have uncovered positive and negative regulators of Hpo/MST, how they are integrated to maintain signaling homeostasis remains poorly understood. Here, we identify a self-restricting mechanism whereby autophosphorylation of an unstructured linker in Hpo/MST creates docking sites for the STRIPAK PP2A phosphatase complex to inactivate Hpo/MST. Mutation of the phospho-dependent docking sites in Hpo/MST or deletion of Slmap, the STRIPAK subunit recognizing these docking sites, results in constitutive activation of Hpo/MST in both Drosophila and mammalian cells. In contrast, autophosphorylation of the Hpo/MST linker at distinct sites is known to recruit Mats/MOB1 to facilitate Hippo signaling. Thus, multisite autophosphorylation of Hpo/MST linker provides an evolutionarily conserved built-in molecular platform to maintain signaling homeostasis by coupling antagonistic signaling activities.
cell.com